Amylyx Pharmaceuticals In... (AMLX)
Amylyx Pharmaceuticals Max Pain By Strike
AMLX trades at $8.01, 14.4% above the near-term max pain of $7 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$95), reflecting growing call interest at higher strikes. Key magnetic zone at 7 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Amylyx Pharmaceuticals Max Pain By Expiry
Max pain for AMLX shows an upward trend from 1 to 95, suggesting bullish positioning in longer-dated options. The 539% spread signals divergent expectations across timeframes. Most levels below 8.01 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 7 | -1.01 (-12.61%) |
| Sep 19, 2025 | 7 | -1.01 (-12.61%) |
| Oct 17, 2025 | 1 | -7.01 (-87.52%) |
| Nov 21, 2025 | 5 | -3.01 (-37.58%) |
| Jan 16, 2026 | 3 | -5.01 (-62.55%) |
| Feb 20, 2026 | 4 | -4.01 (-50.06%) |
| Dec 18, 2026 | 95 | 86.99 (1086.02%) |